The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Enramycin Premix Market Research Report 2024
Synopsis
Enramycin premix is formulated with enramycin, rice bran oil and corn flour. This product is a gray or gray-brown powder with a special odor. It is fermented by actinomycetes and is an unsaturated fatty acid. Polypeptide antibiotics combined with more than a dozen amino acids. It has a strong inhibitory effect on Gram-positive bacteria, and it is not easy to develop drug resistance after long-term use. It can change the distribution of bacterial communities in the intestinal tract, is conducive to the digestion and absorption of feed nutrients, promotes animal growth and improves feed conversion rate, so it is recommended as a pharmaceutical feed additive by many countries in the world. Enramycin is not easily absorbed, so there are fewer drug residues in the body of livestock and poultry.
The global Enramycin Premix market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Enramycin Premix is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Enramycin Premix is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Enramycin Premix include Takeda, AdvaCare, Phiphar Healthcare, Boehringer Ingelheim, Eli Lilly and Company, Ravioza Biotech, Zhejiang Dayang Biology Technology, Bornsun Bioengineering and Shandong Shengli Bioengineering, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Enramycin Premix, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enramycin Premix.
Report Scope
The Enramycin Premix market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enramycin Premix market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enramycin Premix manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
AdvaCare
Phiphar Healthcare
Boehringer Ingelheim
Eli Lilly and Company
Ravioza Biotech
Zhejiang Dayang Biology Technology
Bornsun Bioengineering
Shandong Shengli Bioengineering
Apeloa Pharmaceutical
Hvsen Biotechnology
Segment by Type
Contains Enramycin 4%
Contains Enramycin 8%
Segment by Application
Pig Fodder
Chicken Fodder
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enramycin Premix manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Enramycin Premix by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Enramycin Premix in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Enramycin premix is formulated with enramycin, rice bran oil and corn flour. This product is a gray or gray-brown powder with a special odor. It is fermented by actinomycetes and is an unsaturated fatty acid. Polypeptide antibiotics combined with more than a dozen amino acids. It has a strong inhibitory effect on Gram-positive bacteria, and it is not easy to develop drug resistance after long-term use. It can change the distribution of bacterial communities in the intestinal tract, is conducive to the digestion and absorption of feed nutrients, promotes animal growth and improves feed conversion rate, so it is recommended as a pharmaceutical feed additive by many countries in the world. Enramycin is not easily absorbed, so there are fewer drug residues in the body of livestock and poultry.
The global Enramycin Premix market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Enramycin Premix is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Enramycin Premix is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Enramycin Premix include Takeda, AdvaCare, Phiphar Healthcare, Boehringer Ingelheim, Eli Lilly and Company, Ravioza Biotech, Zhejiang Dayang Biology Technology, Bornsun Bioengineering and Shandong Shengli Bioengineering, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Enramycin Premix, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enramycin Premix.
Report Scope
The Enramycin Premix market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enramycin Premix market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enramycin Premix manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
AdvaCare
Phiphar Healthcare
Boehringer Ingelheim
Eli Lilly and Company
Ravioza Biotech
Zhejiang Dayang Biology Technology
Bornsun Bioengineering
Shandong Shengli Bioengineering
Apeloa Pharmaceutical
Hvsen Biotechnology
Segment by Type
Contains Enramycin 4%
Contains Enramycin 8%
Segment by Application
Pig Fodder
Chicken Fodder
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enramycin Premix manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Enramycin Premix by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Enramycin Premix in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Enramycin Premix Market Overview
1.1 Product Definition
1.2 Enramycin Premix Segment by Type
1.2.1 Global Enramycin Premix Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Contains Enramycin 4%
1.2.3 Contains Enramycin 8%
1.3 Enramycin Premix Segment by Application
1.3.1 Global Enramycin Premix Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Pig Fodder
1.3.3 Chicken Fodder
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Enramycin Premix Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Enramycin Premix Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Enramycin Premix Production Estimates and Forecasts (2019-2030)
1.4.4 Global Enramycin Premix Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Enramycin Premix Production Market Share by Manufacturers (2019-2024)
2.2 Global Enramycin Premix Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Enramycin Premix, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Enramycin Premix Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Enramycin Premix Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Enramycin Premix, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Enramycin Premix, Product Offered and Application
2.8 Global Key Manufacturers of Enramycin Premix, Date of Enter into This Industry
2.9 Enramycin Premix Market Competitive Situation and Trends
2.9.1 Enramycin Premix Market Concentration Rate
2.9.2 Global 5 and 10 Largest Enramycin Premix Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Enramycin Premix Production by Region
3.1 Global Enramycin Premix Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Enramycin Premix Production Value by Region (2019-2030)
3.2.1 Global Enramycin Premix Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Enramycin Premix by Region (2025-2030)
3.3 Global Enramycin Premix Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Enramycin Premix Production by Region (2019-2030)
3.4.1 Global Enramycin Premix Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Enramycin Premix by Region (2025-2030)
3.5 Global Enramycin Premix Market Price Analysis by Region (2019-2024)
3.6 Global Enramycin Premix Production and Value, Year-over-Year Growth
3.6.1 North America Enramycin Premix Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Enramycin Premix Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Enramycin Premix Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Enramycin Premix Production Value Estimates and Forecasts (2019-2030)
4 Enramycin Premix Consumption by Region
4.1 Global Enramycin Premix Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Enramycin Premix Consumption by Region (2019-2030)
4.2.1 Global Enramycin Premix Consumption by Region (2019-2024)
4.2.2 Global Enramycin Premix Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Enramycin Premix Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Enramycin Premix Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Enramycin Premix Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Enramycin Premix Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Enramycin Premix Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Enramycin Premix Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Enramycin Premix Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Enramycin Premix Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Enramycin Premix Production by Type (2019-2030)
5.1.1 Global Enramycin Premix Production by Type (2019-2024)
5.1.2 Global Enramycin Premix Production by Type (2025-2030)
5.1.3 Global Enramycin Premix Production Market Share by Type (2019-2030)
5.2 Global Enramycin Premix Production Value by Type (2019-2030)
5.2.1 Global Enramycin Premix Production Value by Type (2019-2024)
5.2.2 Global Enramycin Premix Production Value by Type (2025-2030)
5.2.3 Global Enramycin Premix Production Value Market Share by Type (2019-2030)
5.3 Global Enramycin Premix Price by Type (2019-2030)
6 Segment by Application
6.1 Global Enramycin Premix Production by Application (2019-2030)
6.1.1 Global Enramycin Premix Production by Application (2019-2024)
6.1.2 Global Enramycin Premix Production by Application (2025-2030)
6.1.3 Global Enramycin Premix Production Market Share by Application (2019-2030)
6.2 Global Enramycin Premix Production Value by Application (2019-2030)
6.2.1 Global Enramycin Premix Production Value by Application (2019-2024)
6.2.2 Global Enramycin Premix Production Value by Application (2025-2030)
6.2.3 Global Enramycin Premix Production Value Market Share by Application (2019-2030)
6.3 Global Enramycin Premix Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Takeda
7.1.1 Takeda Enramycin Premix Corporation Information
7.1.2 Takeda Enramycin Premix Product Portfolio
7.1.3 Takeda Enramycin Premix Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Takeda Main Business and Markets Served
7.1.5 Takeda Recent Developments/Updates
7.2 AdvaCare
7.2.1 AdvaCare Enramycin Premix Corporation Information
7.2.2 AdvaCare Enramycin Premix Product Portfolio
7.2.3 AdvaCare Enramycin Premix Production, Value, Price and Gross Margin (2019-2024)
7.2.4 AdvaCare Main Business and Markets Served
7.2.5 AdvaCare Recent Developments/Updates
7.3 Phiphar Healthcare
7.3.1 Phiphar Healthcare Enramycin Premix Corporation Information
7.3.2 Phiphar Healthcare Enramycin Premix Product Portfolio
7.3.3 Phiphar Healthcare Enramycin Premix Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Phiphar Healthcare Main Business and Markets Served
7.3.5 Phiphar Healthcare Recent Developments/Updates
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Enramycin Premix Corporation Information
7.4.2 Boehringer Ingelheim Enramycin Premix Product Portfolio
7.4.3 Boehringer Ingelheim Enramycin Premix Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Boehringer Ingelheim Main Business and Markets Served
7.4.5 Boehringer Ingelheim Recent Developments/Updates
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Enramycin Premix Corporation Information
7.5.2 Eli Lilly and Company Enramycin Premix Product Portfolio
7.5.3 Eli Lilly and Company Enramycin Premix Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Eli Lilly and Company Main Business and Markets Served
7.5.5 Eli Lilly and Company Recent Developments/Updates
7.6 Ravioza Biotech
7.6.1 Ravioza Biotech Enramycin Premix Corporation Information
7.6.2 Ravioza Biotech Enramycin Premix Product Portfolio
7.6.3 Ravioza Biotech Enramycin Premix Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Ravioza Biotech Main Business and Markets Served
7.6.5 Ravioza Biotech Recent Developments/Updates
7.7 Zhejiang Dayang Biology Technology
7.7.1 Zhejiang Dayang Biology Technology Enramycin Premix Corporation Information
7.7.2 Zhejiang Dayang Biology Technology Enramycin Premix Product Portfolio
7.7.3 Zhejiang Dayang Biology Technology Enramycin Premix Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Zhejiang Dayang Biology Technology Main Business and Markets Served
7.7.5 Zhejiang Dayang Biology Technology Recent Developments/Updates
7.8 Bornsun Bioengineering
7.8.1 Bornsun Bioengineering Enramycin Premix Corporation Information
7.8.2 Bornsun Bioengineering Enramycin Premix Product Portfolio
7.8.3 Bornsun Bioengineering Enramycin Premix Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Bornsun Bioengineering Main Business and Markets Served
7.7.5 Bornsun Bioengineering Recent Developments/Updates
7.9 Shandong Shengli Bioengineering
7.9.1 Shandong Shengli Bioengineering Enramycin Premix Corporation Information
7.9.2 Shandong Shengli Bioengineering Enramycin Premix Product Portfolio
7.9.3 Shandong Shengli Bioengineering Enramycin Premix Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Shandong Shengli Bioengineering Main Business and Markets Served
7.9.5 Shandong Shengli Bioengineering Recent Developments/Updates
7.10 Apeloa Pharmaceutical
7.10.1 Apeloa Pharmaceutical Enramycin Premix Corporation Information
7.10.2 Apeloa Pharmaceutical Enramycin Premix Product Portfolio
7.10.3 Apeloa Pharmaceutical Enramycin Premix Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Apeloa Pharmaceutical Main Business and Markets Served
7.10.5 Apeloa Pharmaceutical Recent Developments/Updates
7.11 Hvsen Biotechnology
7.11.1 Hvsen Biotechnology Enramycin Premix Corporation Information
7.11.2 Hvsen Biotechnology Enramycin Premix Product Portfolio
7.11.3 Hvsen Biotechnology Enramycin Premix Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Hvsen Biotechnology Main Business and Markets Served
7.11.5 Hvsen Biotechnology Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Enramycin Premix Industry Chain Analysis
8.2 Enramycin Premix Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Enramycin Premix Production Mode & Process
8.4 Enramycin Premix Sales and Marketing
8.4.1 Enramycin Premix Sales Channels
8.4.2 Enramycin Premix Distributors
8.5 Enramycin Premix Customers
9 Enramycin Premix Market Dynamics
9.1 Enramycin Premix Industry Trends
9.2 Enramycin Premix Market Drivers
9.3 Enramycin Premix Market Challenges
9.4 Enramycin Premix Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Enramycin Premix Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Enramycin Premix Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Enramycin Premix Production Capacity (K MT) by Manufacturers in 2023
Table 4. Global Enramycin Premix Production by Manufacturers (2019-2024) & (K MT)
Table 5. Global Enramycin Premix Production Market Share by Manufacturers (2019-2024)
Table 6. Global Enramycin Premix Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Enramycin Premix Production Value Share by Manufacturers (2019-2024)
Table 8. Global Enramycin Premix Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Enramycin Premix as of 2023)
Table 10. Global Market Enramycin Premix Average Price by Manufacturers (USD/MT) & (2019-2024)
Table 11. Manufacturers Enramycin Premix Production Sites and Area Served
Table 12. Manufacturers Enramycin Premix Product Types
Table 13. Global Enramycin Premix Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Enramycin Premix Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Enramycin Premix Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Enramycin Premix Production Value Market Share by Region (2019-2024)
Table 18. Global Enramycin Premix Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Enramycin Premix Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Enramycin Premix Production Comparison by Region: 2019 VS 2023 VS 2030 (K MT)
Table 21. Global Enramycin Premix Production (K MT) by Region (2019-2024)
Table 22. Global Enramycin Premix Production Market Share by Region (2019-2024)
Table 23. Global Enramycin Premix Production (K MT) Forecast by Region (2025-2030)
Table 24. Global Enramycin Premix Production Market Share Forecast by Region (2025-2030)
Table 25. Global Enramycin Premix Market Average Price (USD/MT) by Region (2019-2024)
Table 26. Global Enramycin Premix Market Average Price (USD/MT) by Region (2025-2030)
Table 27. Global Enramycin Premix Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (K MT)
Table 28. Global Enramycin Premix Consumption by Region (2019-2024) & (K MT)
Table 29. Global Enramycin Premix Consumption Market Share by Region (2019-2024)
Table 30. Global Enramycin Premix Forecasted Consumption by Region (2025-2030) & (K MT)
Table 31. Global Enramycin Premix Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Enramycin Premix Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K MT)
Table 33. North America Enramycin Premix Consumption by Country (2019-2024) & (K MT)
Table 34. North America Enramycin Premix Consumption by Country (2025-2030) & (K MT)
Table 35. Europe Enramycin Premix Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K MT)
Table 36. Europe Enramycin Premix Consumption by Country (2019-2024) & (K MT)
Table 37. Europe Enramycin Premix Consumption by Country (2025-2030) & (K MT)
Table 38. Asia Pacific Enramycin Premix Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (K MT)
Table 39. Asia Pacific Enramycin Premix Consumption by Region (2019-2024) & (K MT)
Table 40. Asia Pacific Enramycin Premix Consumption by Region (2025-2030) & (K MT)
Table 41. Latin America, Middle East & Africa Enramycin Premix Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (K MT)
Table 42. Latin America, Middle East & Africa Enramycin Premix Consumption by Country (2019-2024) & (K MT)
Table 43. Latin America, Middle East & Africa Enramycin Premix Consumption by Country (2025-2030) & (K MT)
Table 44. Global Enramycin Premix Production (K MT) by Type (2019-2024)
Table 45. Global Enramycin Premix Production (K MT) by Type (2025-2030)
Table 46. Global Enramycin Premix Production Market Share by Type (2019-2024)
Table 47. Global Enramycin Premix Production Market Share by Type (2025-2030)
Table 48. Global Enramycin Premix Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Enramycin Premix Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Enramycin Premix Production Value Share by Type (2019-2024)
Table 51. Global Enramycin Premix Production Value Share by Type (2025-2030)
Table 52. Global Enramycin Premix Price (USD/MT) by Type (2019-2024)
Table 53. Global Enramycin Premix Price (USD/MT) by Type (2025-2030)
Table 54. Global Enramycin Premix Production (K MT) by Application (2019-2024)
Table 55. Global Enramycin Premix Production (K MT) by Application (2025-2030)
Table 56. Global Enramycin Premix Production Market Share by Application (2019-2024)
Table 57. Global Enramycin Premix Production Market Share by Application (2025-2030)
Table 58. Global Enramycin Premix Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Enramycin Premix Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Enramycin Premix Production Value Share by Application (2019-2024)
Table 61. Global Enramycin Premix Production Value Share by Application (2025-2030)
Table 62. Global Enramycin Premix Price (USD/MT) by Application (2019-2024)
Table 63. Global Enramycin Premix Price (USD/MT) by Application (2025-2030)
Table 64. Takeda Enramycin Premix Corporation Information
Table 65. Takeda Specification and Application
Table 66. Takeda Enramycin Premix Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 67. Takeda Main Business and Markets Served
Table 68. Takeda Recent Developments/Updates
Table 69. AdvaCare Enramycin Premix Corporation Information
Table 70. AdvaCare Specification and Application
Table 71. AdvaCare Enramycin Premix Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. AdvaCare Main Business and Markets Served
Table 73. AdvaCare Recent Developments/Updates
Table 74. Phiphar Healthcare Enramycin Premix Corporation Information
Table 75. Phiphar Healthcare Specification and Application
Table 76. Phiphar Healthcare Enramycin Premix Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Phiphar Healthcare Main Business and Markets Served
Table 78. Phiphar Healthcare Recent Developments/Updates
Table 79. Boehringer Ingelheim Enramycin Premix Corporation Information
Table 80. Boehringer Ingelheim Specification and Application
Table 81. Boehringer Ingelheim Enramycin Premix Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Boehringer Ingelheim Main Business and Markets Served
Table 83. Boehringer Ingelheim Recent Developments/Updates
Table 84. Eli Lilly and Company Enramycin Premix Corporation Information
Table 85. Eli Lilly and Company Specification and Application
Table 86. Eli Lilly and Company Enramycin Premix Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Eli Lilly and Company Main Business and Markets Served
Table 88. Eli Lilly and Company Recent Developments/Updates
Table 89. Ravioza Biotech Enramycin Premix Corporation Information
Table 90. Ravioza Biotech Specification and Application
Table 91. Ravioza Biotech Enramycin Premix Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Ravioza Biotech Main Business and Markets Served
Table 93. Ravioza Biotech Recent Developments/Updates
Table 94. Zhejiang Dayang Biology Technology Enramycin Premix Corporation Information
Table 95. Zhejiang Dayang Biology Technology Specification and Application
Table 96. Zhejiang Dayang Biology Technology Enramycin Premix Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Zhejiang Dayang Biology Technology Main Business and Markets Served
Table 98. Zhejiang Dayang Biology Technology Recent Developments/Updates
Table 99. Bornsun Bioengineering Enramycin Premix Corporation Information
Table 100. Bornsun Bioengineering Specification and Application
Table 101. Bornsun Bioengineering Enramycin Premix Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Bornsun Bioengineering Main Business and Markets Served
Table 103. Bornsun Bioengineering Recent Developments/Updates
Table 104. Shandong Shengli Bioengineering Enramycin Premix Corporation Information
Table 105. Shandong Shengli Bioengineering Specification and Application
Table 106. Shandong Shengli Bioengineering Enramycin Premix Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Shandong Shengli Bioengineering Main Business and Markets Served
Table 108. Shandong Shengli Bioengineering Recent Developments/Updates
Table 109. Apeloa Pharmaceutical Enramycin Premix Corporation Information
Table 110. Apeloa Pharmaceutical Specification and Application
Table 111. Apeloa Pharmaceutical Enramycin Premix Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Apeloa Pharmaceutical Main Business and Markets Served
Table 113. Apeloa Pharmaceutical Recent Developments/Updates
Table 114. Hvsen Biotechnology Enramycin Premix Corporation Information
Table 115. Hvsen Biotechnology Specification and Application
Table 116. Hvsen Biotechnology Enramycin Premix Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Hvsen Biotechnology Main Business and Markets Served
Table 118. Hvsen Biotechnology Recent Developments/Updates
Table 119. Key Raw Materials Lists
Table 120. Raw Materials Key Suppliers Lists
Table 121. Enramycin Premix Distributors List
Table 122. Enramycin Premix Customers List
Table 123. Enramycin Premix Market Trends
Table 124. Enramycin Premix Market Drivers
Table 125. Enramycin Premix Market Challenges
Table 126. Enramycin Premix Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Enramycin Premix
Figure 2. Global Enramycin Premix Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Enramycin Premix Market Share by Type: 2023 VS 2030
Figure 4. Contains Enramycin 4% Product Picture
Figure 5. Contains Enramycin 8% Product Picture
Figure 6. Global Enramycin Premix Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Enramycin Premix Market Share by Application: 2023 VS 2030
Figure 8. Pig Fodder
Figure 9. Chicken Fodder
Figure 10. Others
Figure 11. Global Enramycin Premix Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Enramycin Premix Production Value (US$ Million) & (2019-2030)
Figure 13. Global Enramycin Premix Production Capacity (K MT) & (2019-2030)
Figure 14. Global Enramycin Premix Production (K MT) & (2019-2030)
Figure 15. Global Enramycin Premix Average Price (USD/MT) & (2019-2030)
Figure 16. Enramycin Premix Report Years Considered
Figure 17. Enramycin Premix Production Share by Manufacturers in 2023
Figure 18. Enramycin Premix Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. The Global 5 and 10 Largest Players: Market Share by Enramycin Premix Revenue in 2023
Figure 20. Global Enramycin Premix Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 21. Global Enramycin Premix Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 22. Global Enramycin Premix Production Comparison by Region: 2019 VS 2023 VS 2030 (K MT)
Figure 23. Global Enramycin Premix Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 24. North America Enramycin Premix Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. Europe Enramycin Premix Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. China Enramycin Premix Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Japan Enramycin Premix Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. Global Enramycin Premix Consumption by Region: 2019 VS 2023 VS 2030 (K MT)
Figure 29. Global Enramycin Premix Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Enramycin Premix Consumption Market Share by Country (2019-2030)
Figure 32. Canada Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 33. U.S. Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 34. Europe Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 35. Europe Enramycin Premix Consumption Market Share by Country (2019-2030)
Figure 36. Germany Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 37. France Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 38. U.K. Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 39. Italy Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 40. Russia Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 41. Asia Pacific Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Enramycin Premix Consumption Market Share by Regions (2019-2030)
Figure 43. China Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 44. Japan Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 45. South Korea Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 46. China Taiwan Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 47. Southeast Asia Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 48. India Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 49. Latin America, Middle East & Africa Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 50. Latin America, Middle East & Africa Enramycin Premix Consumption Market Share by Country (2019-2030)
Figure 51. Mexico Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 52. Brazil Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 53. Turkey Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 54. GCC Countries Enramycin Premix Consumption and Growth Rate (2019-2024) & (K MT)
Figure 55. Global Production Market Share of Enramycin Premix by Type (2019-2030)
Figure 56. Global Production Value Market Share of Enramycin Premix by Type (2019-2030)
Figure 57. Global Enramycin Premix Price (USD/MT) by Type (2019-2030)
Figure 58. Global Production Market Share of Enramycin Premix by Application (2019-2030)
Figure 59. Global Production Value Market Share of Enramycin Premix by Application (2019-2030)
Figure 60. Global Enramycin Premix Price (USD/MT) by Application (2019-2030)
Figure 61. Enramycin Premix Value Chain
Figure 62. Enramycin Premix Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Food & Beverages Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
